Gene · 6392
Papers2,836
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,836
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A case report of an intracardiac paraganglioma attached to the left main coronary artery in a patient with a succinate dehydrogenase complex subunit D mutation. | Eur Heart J Case Rep | 2023 | 37811153 | PubTator, text mining | PubMed |
| Succinate metabolism: a promising therapeutic target for inflammation, ischemia/reperfusion injury and cancer. | Front Cell Dev Biol | 2023 | 37808079 | PubTator, text mining | PubMed |
| Single-cell transcriptome sequencing reveals tumor heterogeneity in family neuroblastoma. | Front Immunol | 2023 | 37790931 | PubTator, text mining | PubMed |
| Mixed Corticomedullary Tumor of the Adrenal Gland: A Case Report and Literature Review. | Medicina (Kaunas) | 2023 | 37763658 | PubTator, text mining | PubMed |
| A Laboratory Medicine Perspective on the Investigation of Phaeochromocytoma and Paraganglioma. | Diagnostics (Basel) | 2023 | 37761307 | PubTator, text mining | PubMed |
| Image-Guided Precision Medicine in the Diagnosis and Treatment of Pheochromocytomas and Paragangliomas. | Cancers (Basel) | 2023 | 37760633 | PubTator, text mining | PubMed |
| CHSY1 promotes CD8+ T cell exhaustion through activation of succinate metabolism pathway leading to colorectal cancer liver metastasis based on CRISPR/Cas9 screening. | J Exp Clin Cancer Res | 2023 | 37749638 | PubTator, text mining | PubMed |
| Identification of potential molecular targets for the treatment of cluster 1 human pheochromocytoma and paraganglioma via comprehensive proteomic characterization. | Clin Proteomics | 2023 | 37749499 | PubTator, text mining | PubMed |
| Pheochromocytoma: A Troublesome Tumor. | Cureus | 2023 | 37727845 | PubTator, text mining | PubMed |
| Advancing precision oncology through systematic germline and tumor genetic analysis: The oncogenetic point of view on findings from a prospective multicenter clinical trial of 666 patients. | Cancer Med | 2023 | 37694493 | PubTator, text mining | PubMed |
| Integrative analysis of mitochondrial metabolic reprogramming in early-stage colon and liver cancer. | Front Oncol | 2023 | 37692839 | PubTator, text mining | PubMed |
Cyclin dependent kinase inhibitor 3 (CDKN3) upregulation is associated with unfavorable prognosis in clear cell renal cell carcinoma and shapes tumor immune microenvironment: A bioinformatics analysis. | Medicine (Baltimore) | 2023 | 37682177 | PubTator, text mining | PubMed |
| Global trends and current status in pheochromocytoma: a bibliometric analysis of publications in the last 20 years. | Front Endocrinol (Lausanne) | 2023 | 37680890 | PubTator, text mining | PubMed |
| Intravenous BCG vaccination reduces SARS-CoV-2 severity and promotes extensive reprogramming of lung immune cells. | iScience | 2023 | 37674985 | PubTator, text mining | PubMed |
| Neck Ganglioneuroma Mimicking a Thyroid Nodule in a Four-Year-Old Child: A Case Report and Review of the Literature. | Int J Endocrinol Metab | 2023 | 37662645 | PubTator, text mining | PubMed |
| Investigation of germline variants in Bahraini women with breast cancer using next-generation sequencing based-multigene panel. | PLoS One | 2023 | 37656691 | PubTator, text mining | PubMed |
| 2023 GEIS Guidelines for gastrointestinal stromal tumors. | Ther Adv Med Oncol | 2023 | 37655207 | PubTator, text mining | PubMed |
| Comparative analysis of the complete mitogenome of Geoffroea decorticans: a native tree surviving in the Atacama Desert. | Front Genet | 2023 | 37636265 | PubTator, text mining | PubMed |
| Leigh Syndrome Spectrum: A Portuguese Population Cohort in an Evolutionary Genetic Era. | Genes (Basel) | 2023 | 37628588 | PubTator, text mining | PubMed |
| Hypoxic State of Cells and Immunosenescence: A Focus on the Role of the HIF Signaling Pathway. | Biomedicines | 2023 | 37626660 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6392/papers?page=11